| Illumina Q1 2010 Earnings Call Transcript Illumina (ILMN)Q1 2010 Earnings CallApril 28, 2010 5:00 pm ETComplete Story » seekingalpha.com |
New Effort Launched for Clinical Drug Trials New York state medical centers and drug makers are launching an initiative to address a nettlesome problem for clinical drug trials: getting patients to sign up. online.wsj.com |
Alere's Dr. Gordon Norman Provides Insights Into Putting the Nation's Broken Healthcare System 'Back Together Again' (PR Newswire) Like all the King's men in the Humpty Dumpty nursery rhyme, U.S. healthcare leaders are searching for ways to put our fractured healthcare system "back together again." Â That fact and analogy are focal points of a presentation by Gordon Norman, MD, chief innovation officer for Alere, at the Seventh Annual Healthcare Unbound Conference, July 19-20 in San Diego. Â us.rd.yahoo.com |
RadNet to Acquire Imaging Centers in Northern New Jersey From Progressive Health [GlobeNewswire] - LOS ANGELES -- RadNet, Inc. , a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 191 fully-owned and operated outpatient imaging centers, today reported it has executed a definitive agreement to acquire five imaging centers in Northern New Jersey and a 50% equity interest in a sixth center from Progressive Health, LLC and certain affiliates and related entities. us.rd.yahoo.com |
Nicusa Capital Calls for Leadership Changes at BioClinica [PR Newswire] - Nicusa Capital is calling for the resignations of Dr. David Nowicki as Chairman of the Board, Mr. Mark Weinstein as CEO, and Mr. Ted Kaminer as CFO of BioClinica, Inc. . Â Nicusa owns 854,119 shares, or approximately 5.6%, of the Company's shares. Â We believe that BioClinica's core imaging business is worth substantially more than the current stock price, but management's corporate strategy is flawed and is destroying shareholder value. Â We have communicated our concerns to the Board of Directors on several occasions and, in June 2010, we publicized these concerns in a 13D filing. Â us.rd.yahoo.com |